Dr. Jan Claas has 30 years of experience in the health care industry covering an extremely broad spectrum from Pre-clinical Research to General Management (GM).

His vast international experience is based on a 5,5-years GM position in UK, a 4,5-years regional GM-EU role and a 6-years collaboration with an US based global player (Johnson & Johnson).

Key strengths are the success­ful launch of innovative brands with creative concepts to drive market development as well as the leadership of complex organizations with proven success.

  • Successful General Management (GM) roles with full P&L responsibility over 10 years in large EU country (UK and Ireland) and an EU region (EU Cluster) → Leadership responsibility for up to 250 employees with diverse and broad international background
  • Broad Know-how in the pharmaceutical industry in preclinical Research (PhD), Medical Affairs and local and international Marketing up to a Senior VP position, covering a broad range of indications (Pain, CNS, Oncology and Infectiology)
  • International launch of innovations including responsibility for commercial development from clinical phase 2 onwards 
  • Key role in global commercial collaboration with global player (J&J/US) during a period of 6 years
  • Dedication to execution, resulting in sustainable turnaround (UK) and significant improvement of efficiency (EU Cluster/UK)
  • Successful leadership based on a style focused on motivation and trust
  • Extensive international experience (UK, EU & US) and intercultural learnings from working with very diverse teams

Major achievements in business

  • Responsible for the most successful launch in the company’s history: Made „PALEXIA” to Grünenthal’s key growth and profit driver
  • Sustainable turnaround in UK organization: Increased UK profitability within 5 years from -23 % to +33 % by resolving all issues regarding growth of innovations, company-profit and compliance
  • Significant improvement of profit (plus 43 M€) and profitability (plus 25 %) by setting up a new organizational structure for the smaller and mid-sized EU countries (EU Cluster)